*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter - as a primary diagnosis code | T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 6.59 | |
| Readmission Rate (%) | 28.19 | |
| Unplanned Readmission Rate (%) | 18.33 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 71,748 | |
| Total Hospitalizations with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 67 | |
| DRG Share of Total Hospitalizations | 0.22 | |
| % of Total ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter in DRG | 54.92 | |
| Avg LOS at DRG | 2.93 | |
| Avg LOS with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 3.75 | |
| Readmission Rate at DRG | 33.86 | |
| Readmission Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 26.87 | |
| Unplanned Readmission Rate at DRG | 10.34 | |
| Unplanned Readmission Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 16.42 | |
| Total Medicare payments at DRG | $313,351,773 | |
| Total Medicare payments with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $325,069 | |
| Total Medicare payment per Day at DRG | $1,489 | |
| Total Medicare payment per Day with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $1,295 | |
| Total Medicare payment per Hospitalization at DRG | $4,367 | |
| Total Medicare payment per Hospitalization with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $4,852 | |
| Total Medicare Charges at DRG | $1,750,048,705 | |
| Total Medicare Charges with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $1,479,438 | |
| Avg Charges at DRG | $24,392 | |
| Avg Charges with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $22,081 | |
| Mortality Rate at DRG | 0.22 | |
| Mortality Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | NA | |
| SNF Discharge Rate at DRG | 7.61 | |
| SNF Discharge Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | NA | |
| Home Discharge Rate at DRG | 51.88 | |
| Home Discharge Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 62.69 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 535,322 | ||||
| Total Hospitalizations with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 38,094 | ||||
| DRG Share of Total Hospitalizations | 1.63 | ||||
| % of Total ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter in DRG | 10.14 | ||||
| Avg LOS at DRG | 4.68 | ||||
| Avg LOS with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 5.44 | ||||
| Readmission Rate at DRG | 23.65 | ||||
| Readmission Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 24.81 | ||||
| Unplanned Readmission Rate at DRG | 18.66 | ||||
| Unplanned Readmission Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 20.07 | ||||
| Total Medicare payments at DRG | $3,844,806,408 | ||||
| Total Medicare payments with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $275,296,047 | ||||
| Total Medicare payment per Day at DRG | $1,536 | ||||
| Total Medicare payment per Day with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $1,328 | ||||
| Total Medicare payment per Hospitalization at DRG | $7,182 | ||||
| Total Medicare payment per Hospitalization with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $7,227 | ||||
| Total Medicare Charges at DRG | $19,258,468,078 | ||||
| Total Medicare Charges with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $1,561,785,012 | ||||
| Avg Charges at DRG | $35,975 | ||||
| Avg Charges with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $40,998 | ||||
| Mortality Rate at DRG | 1.27 | ||||
| Mortality Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 0.8 | ||||
| SNF Discharge Rate at DRG | 14.61 | ||||
| SNF Discharge Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 14.23 | ||||
| Home Discharge Rate at DRG | 52.12 | ||||
| Home Discharge Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 52.55 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 443,386 | ||||
| Total Hospitalizations with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 13,226 | ||||
| DRG Share of Total Hospitalizations | 1.35 | ||||
| % of Total ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter in DRG | 3.52 | ||||
| Avg LOS at DRG | 5.27 | ||||
| Avg LOS with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 6.32 | ||||
| Readmission Rate at DRG | 21.6 | ||||
| Readmission Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 23.69 | ||||
| Unplanned Readmission Rate at DRG | 15.91 | ||||
| Unplanned Readmission Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 17.54 | ||||
| Total Medicare payments at DRG | $3,812,834,208 | ||||
| Total Medicare payments with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $115,063,625 | ||||
| Total Medicare payment per Day at DRG | $1,632 | ||||
| Total Medicare payment per Day with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $1,377 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,599 | ||||
| Total Medicare payment per Hospitalization with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $8,700 | ||||
| Total Medicare Charges at DRG | $18,110,468,211 | ||||
| Total Medicare Charges with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $668,180,583 | ||||
| Avg Charges at DRG | $40,846 | ||||
| Avg Charges with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $50,520 | ||||
| Mortality Rate at DRG | 3.59 | ||||
| Mortality Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 2.03 | ||||
| SNF Discharge Rate at DRG | 22.57 | ||||
| SNF Discharge Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 18.79 | ||||
| Home Discharge Rate at DRG | 40.95 | ||||
| Home Discharge Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 47.15 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 025: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 652: KIDNEY TRANSPLANT | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,522,684 | ||||
| Total Hospitalizations with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 4,969 | ||||
| DRG Share of Total Hospitalizations | 4.63 | ||||
| % of Total ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter in DRG | 1.32 | ||||
| Avg LOS at DRG | 2.52 | ||||
| Avg LOS with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 2.63 | ||||
| Readmission Rate at DRG | 9.03 | ||||
| Readmission Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 10.64 | ||||
| Unplanned Readmission Rate at DRG | 3.35 | ||||
| Unplanned Readmission Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 4.58 | ||||
| Total Medicare payments at DRG | $17,672,828,347 | ||||
| Total Medicare payments with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $58,046,154 | ||||
| Total Medicare payment per Day at DRG | $4,606 | ||||
| Total Medicare payment per Day with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $4,446 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,606 | ||||
| Total Medicare payment per Hospitalization with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $11,682 | ||||
| Total Medicare Charges at DRG | $91,836,200,128 | ||||
| Total Medicare Charges with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $338,687,216 | ||||
| Avg Charges at DRG | $60,312 | ||||
| Avg Charges with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $68,160 | ||||
| Mortality Rate at DRG | 0.05 | ||||
| Mortality Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 23.53 | ||||
| SNF Discharge Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 23.41 | ||||
| Home Discharge Rate at DRG | 30.67 | ||||
| Home Discharge Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 27.39 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 054: NERVOUS SYSTEM NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 43,598 | ||||
| Total Hospitalizations with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 3,452 | ||||
| DRG Share of Total Hospitalizations | 0.13 | ||||
| % of Total ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter in DRG | 0.92 | ||||
| Avg LOS at DRG | 5.58 | ||||
| Avg LOS with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 6.99 | ||||
| Readmission Rate at DRG | 27.89 | ||||
| Readmission Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 33.72 | ||||
| Unplanned Readmission Rate at DRG | 14.61 | ||||
| Unplanned Readmission Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 19.0 | ||||
| Total Medicare payments at DRG | $420,580,748 | ||||
| Total Medicare payments with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $35,435,764 | ||||
| Total Medicare payment per Day at DRG | $1,728 | ||||
| Total Medicare payment per Day with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $1,469 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,647 | ||||
| Total Medicare payment per Hospitalization with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $10,265 | ||||
| Total Medicare Charges at DRG | $2,165,508,049 | ||||
| Total Medicare Charges with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $208,472,742 | ||||
| Avg Charges at DRG | $49,670 | ||||
| Avg Charges with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | $60,392 | ||||
| Mortality Rate at DRG | 4.23 | ||||
| Mortality Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 2.95 | ||||
| SNF Discharge Rate at DRG | 18.01 | ||||
| SNF Discharge Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 23.64 | ||||
| Home Discharge Rate at DRG | 29.57 | ||||
| Home Discharge Rate with ICD T380X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 27.61 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| NCH BAKER HOSPITAL DOWNTOWN | 350 7TH ST N | NAPLES | FL | 34102 | 1,131 |
| HOUSTON METHODIST HOSPITAL | 6565 FANNIN ST | HOUSTON | TX | 77030 | 1,122 |
| RUSH UNIVERSITY MEDICAL CENTER | 1653 W CONGRESS PKWY | CHICAGO | IL | 60612 | 1,114 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. GAVAN PATRICK DUFFY | 10475 CENTURION PKWY N | JACKSONVILLE | FL | 32256 | 340 |
| Dr. JASON ERIC REISS | 1641 TAMIAMI TRL | PORT CHARLOTTE | FL | 33948 | 155 |
| Dr. HOWARD J KAPP | 130 TAMIAMI TRL N | NAPLES | FL | 34102 | 137 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. GAVAN PATRICK DUFFY | 10475 CENTURION PKWY N | JACKSONVILLE | FL | 32256 | 342 |
| Dr. ZIAD SOUS | 1145 S UTICA AVE | TULSA | OK | 74104 | 212 |
| Dr. RAJESH AGARWAL | 6770 MAYFIELD RD | MAYFIELD HEIGHTS | OH | 44124 | 184 |